Get the latest tech news
Big Pharma claims lower prices means giving up miracle medications. Ignore them
Critics warn new medicines could be lost by reducing out-of-pocket costs. But there are good reasons to be optimistic about future medical research.
The historic policy, which has been floating around for decades, was long opposed by “Big Pharma” until Democrats in Congress passed and President Joe Biden signed the Inflation Reduction Act in 2022. The research — from Memorial Sloan Kettering Cancer Center’s Nancy Yu, Zachary Helms, and Peter Bach — determined the excess price paid in the US compared to other wealthy nations. New start-ups, such as Recursion Pharmaceuticals, profiled by STAT, have based their entire business on using AI to find potential drug candidates, including among those sitting on the shelves of Big Pharma that could be repurposed for new conditions.
Or read this on Hacker News
